Modification of bone graft by blending with lecithin to improve hydrophilicity and biocompatibility
Source abstract
Abstract
Lecithin was blended to improve the hydrophilicity and biocompatibility of bone graft containing poly(l-lactic acid) (PLLA). Solution blending and freeze drying were used to fabricate symmetrical scaffolds containing different percentages of lecithin (lecithin: PLLA = 0, 5, 10 wt%). Scanning electron microscopy showed that the scaffolds maintained the three-dimensional porous structure. A water uptake experiment proved the significant improvement of hydrophilicity of the blend scaffold. With the addition of lecithin, the compressive strength and compressive modulus decreased. When the weight ratio of lecithin to PLLA was up to 10%, the compressive strength was still more than the lower limit of natural cancellous bone. To test the biocompatibility of the scaffolds, cell culture in vitro and subcutaneous implantation in vivo were performed. MC3T3-E1 preosteoblastic cells were cultured on the scaffolds for 7 days. Methylthiazol tetrazolium assay and laser scanning confocal microscopy were used to exhibit proliferation and morphology of the cells. The subcutaneous implantation in rats tested inflammatory response to the scaffolds. The results proved the better biocompatibility and milder inflammatory reactions of the blend scaffold (lecithin: PLLA = 5%) compared with the scaffold without lecithin. The modified scaffold containing lecithin is promising for bone tissue engineering.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. 10.1097/00007632-200104150-0001710.1097/00007632-200104150-00017 ↗
2. 10.1126/science.849352910.1126/science.8493529 ↗
3. 10.1177/088532820607370610.1177/0885328206073706 ↗
4. 10.1016/j.surfcoat.2007.04.03510.1016/j.surfcoat.2007.04.035 ↗
5. Zhang C · Biomed. Mater. · 2006 · 1 · 5610.1088/1748-6041/1/2/002 ↗
6. 10.1097/00007632-200303010-0000410.1097/00007632-200303010-00004 ↗
7. 10.1097/00007632-200302150-0001210.1097/00007632-200302150-00012 ↗
8. 10.1097/00005131-199105020-0001810.1097/00005131-199105020-00018 ↗
9. 10.1097/00003086-200006000-0003110.1097/00003086-200006000-00031 ↗
10. 10.1097/00007632-199811010-0000510.1097/00007632-199811010-00005 ↗
11. 10.1016/S0142-9612(00)00305-710.1016/S0142-9612(00)00305-7 ↗
12. 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-910.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9 ↗
13. 10.1097/01.BRS.0000083240.13332.F610.1097/01.BRS.0000083240.13332.F6 ↗
14. 10.1089/10763270432279171810.1089/107632704322791718 ↗
15. 10.1002/jbm.b.2003510.1002/jbm.b.20035 ↗
16. Wang Y · J. Biomed. Mater. Res. · 2007
17. 10.1002/jbm.a.3144010.1002/jbm.a.31440 ↗
18. 10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I ↗
19. 10.1016/S0079-6700(98)00015-X10.1016/S0079-6700(98)00015-X ↗
20. 10.1126/science.111979010.1126/science.1119790 ↗
21. 10.1002/jbm.a.3115910.1002/jbm.a.31159 ↗
22. 10.1016/j.jcrysgro.2006.03.00610.1016/j.jcrysgro.2006.03.006 ↗
23. 10.1016/j.compscitech.2007.01.00910.1016/j.compscitech.2007.01.009 ↗
24. Mădălina V N · Biomed. Mater. · 2007 · 2 · 24110.1088/1748-6041/2/4/006 ↗
25. 10.1083/jcb.96.1.19110.1083/jcb.96.1.191 ↗
26. 10.1016/0142-9612(85)90101-210.1016/0142-9612(85)90101-2 ↗
27. 10.1016/0142-9612(87)90001-910.1016/0142-9612(87)90001-9 ↗
28. 10.1006/jcis.1998.568810.1006/jcis.1998.5688 ↗
29. 10.1016/0021-9290(85)90287-810.1016/0021-9290(85)90287-8 ↗
30. 10.1177/088391150404264310.1177/0883911504042643 ↗
31. 10.1016/j.febslet.2004.07.05710.1016/j.febslet.2004.07.057 ↗
32. 10.1002/jbm.a.3060210.1002/jbm.a.30602 ↗